Roche (Roche Holding AG) is a global healthcare company headquartered in Basel, Switzerland, focused on the research, development, and manufacturing of pharmaceuticals and diagnostics. The group operates through two core divisions—Pharmaceuticals and Diagnostics—and includes subsidiaries such as Genentech in the United States and Chugai in Japan.
For the chemical and life sciences value chain, Roche develops small‑molecule medicines and active pharmaceutical ingredients (APIs) alongside a broad portfolio of biologics, including monoclonal and bispecific antibodies. Its capabilities span process chemistry, analytical development, scale‑up, and GMP manufacturing, as well as large‑scale cell culture, purification, and fill‑finish operations. The Diagnostics division provides in vitro diagnostic systems, reagents, and molecular testing technologies. Roche’s therapeutic focus areas include oncology, immunology, infectious diseases, neuroscience, and ophthalmology. The company maintains a global R&D and manufacturing network and emphasizes regulatory compliance, quality, and reliable supply across its operations.
To provide comprehensive coverage, we aggregate data and news under the name Roche, encompassing the following company names, divisions, and related entities:
Roche Group and Roche Holding AG.
This list encompasses current and former names, alternate names, and key divisions associated with Roche, ensuring you can easily find all relevant information under a single, unified profile.
